Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn's Disease Patients.

Gut Liver · 2022 · PMC8761917 · PMID 34092576

Europe PMC DOI

hedged sentence

0.0160

closest p · 0.3× alpha

0.0160

boldest claim

The sentences

a significant trendp=0.016actually significant

Relapse-free survival curve showed a significant trend with a poorer outcome in patients with AGR <1.47 compared to those with ≥1.47 (log-rank test p=0.016) ( Fig. 2 ). 4.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.